Author Correction: Drug screening of cancer cell lines and human primary tumors using droplet microfluidics (Scientific Reports, (2017), 7, 1, (9109), 10.1038/s41598-017-08831-z);Drug screening of cancer cell lines and human primary tumors using droplet microfluidics

Scientific Reports

Volumn 7, Issue 1, 2017, Pages

  Wong, Ada Hang Heng ^a   Li, Haoran ^b   Jia, Yanwei ^b   Mak, Pui In ^b,c   Martins, Rui Paulo Da Silva ^b,c,d   Liu, Yan ^c   Vong, Chi Man ^c   Wong, Hang Cheong ^c   Wong, Pak Kin ^c   Wang, Haitao ^a   Sun, Heng ^a   Deng, Chu Xia ^a  

^a University of Macau   (Macao)

^b China   (Macao)

^c UNIVERSITY OF MACAU   (Macao)

^d INSTITUTO SUPERIOR TÉCNICO   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

CELL SURVIVAL; DRUG EFFECT; DRUG SCREENING; HIGH THROUGHPUT SCREENING; HUMAN; LAB ON A CHIP; MICROFLUIDIC ANALYSIS; MICROFLUIDICS; PRECLINICAL STUDY; PROCEDURES; REPRODUCIBILITY; SINGLE CELL ANALYSIS; TUMOR CELL CULTURE; TUMOR CELL LINE;

CELL LINE, TUMOR; CELL SURVIVAL; DRUG EVALUATION, PRECLINICAL; DRUG SCREENING ASSAYS, ANTITUMOR; HIGH-THROUGHPUT SCREENING ASSAYS; HUMANS; LAB-ON-A-CHIP DEVICES; MICROFLUIDIC ANALYTICAL TECHNIQUES; MICROFLUIDICS; REPRODUCIBILITY OF RESULTS; SINGLE-CELL ANALYSIS; TUMOR CELLS, CULTURED;

EID: 85028063679     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/s41598-019-55120-y     Document Type: Erratum

References (33)

1. Wong, A. H. & Deng, C. X. Precision Medicine for Personalized Cancer Therapy. Int J Biol Sci 11, 1410-1412, doi: 10.7150/ijbs.14154 (2015).
2. Stewart, B. W. & Wild, C. International Agency for Research on Cancer & World Health Organization. World cancer report 2014. (International Agency for Research on Cancer WHO Press, 2014).
3. Baker, F. L. et al. Drug and radiation sensitivity measurements of successful primary monolayer culturing of human tumor cells using cell-adhesive matrix and supplemented medium. Cancer Res 46, 1263-1274 (1986).
4. Kobayashi, S. & Fujimura, S. Characterization and the clinical application of cultured human pulmonary carcinoma cells. Tohoku J Exp Med 168, 375-386 (1992).
5. Nikkhah, G. et al. The MTT assay for chemosensitivity testing of human tumors of the central nervous system. Part II: Evaluation of patient-and drug-specific variables. J Neurooncol 13, 13-24 (1992).
6. Wibe, E., Berg, J. P., Tveit, K. M., Nesland, J. M. & Lunde, S. Multicellular spheroids grown directly from human tumour material. Int J Cancer 34, 21-26 (1984).
7. Friedrich, J., Seidel, C., Ebner, R. & Kunz-Schughart, L. A. Spheroid-based drug screen: considerations and practical approach. Nat Protoc 4, 309-324, doi: 10.1038/nprot.2008.226 (2009).
8. Goldie, H., Jeffries, B. R., Green, S. S. & Simpson, M. R. Primary growth of leukemic cells as a factor in their metastatic growth and in their lethal effect on the mouse. Cancer Res 14, 423-427 (1954).
9. Shorthouse, A. J. et al. The human tumour xenograft-a valid model in experimental chemotherapy Br J Surg 67, 715-722 (1980).
10. Yu, M. et al. Cancer therapy. Ex vivo culture of circulating breast tumor cells for individualized testing of drug susceptibility. Science 345, 216-220, doi: 10.1126/science.1253533 (2014).
11. Kim, H. S., Devarenne, T. P. & Han, A. A high-throughput microfluidic single-cell screening platform capable of selective cell extraction. Lab on a Chip 15, 2467-2475, doi: 10.1039/C4LC01316F (2015).
12. Greenman, C. et al. Patterns of somatic mutation in human cancer genomes. Nature 446, 153-158, doi: 10.1038/nature05610 (2007).
13. Miller, O. J. et al. High-resolution dose-response screening using droplet-based microfluidics. Proc Natl Acad Sci USA 109, 378-383, doi: 10.1073/pnas.1113324109 (2012).
14. Ding, Y. et al. Microfluidic-Enabled Print-to-Screen (P2S) Platform for High-Throughput Screening of Combinatorial Chemotherapy. Anal Chem. doi: 10.1021/acs.analchem.5b00826 (2015).
15. Ozkumur, A. Y., Goods, B. A. & Love, J. C. Development of a High-Throughput Functional Screen Using Nanowell-Assisted Cell Patterning. Small 11, 4643-4650, doi: 10.1002/smll.201500674 (2015).
16. Matsumoto, Y. et al. A Microfluidic Channel Method for Rapid Drug-Susceptibility Testing of Pseudomonas aeruginosa. PLoS One 11, e0148797, doi: 10.1371/journal.pone.0148797 (2016).
17. Eriksson, A. et al. Drug screen in patient cells suggests quinacrine to be repositioned for treatment of acute myeloid leukemia. Blood Cancer J 5, e307, doi: 10.1038/bcj.2015.31 (2015).
18. Xu, Z. Y. et al. Application of a microfluidic chip-based 3D co-culture to test drug sensitivity for individualized treatment of lung cancer. Biomaterials 34, 4109-4117, doi: 10.1016/j.biomaterials.2013.02.045 (2013).
19. Khin, Z. P. et al. A preclinical assay for chemosensitivity in multiple myeloma. Cancer Res 74, 56-67, doi: 10.1158/0008-5472.CAN-13-2397 (2014).
20. Jonas, O. et al. An implantable microdevice to perform high-throughput in vivo drug sensitivity testing in tumors. Sci Transl Med 7, 284ra257, doi: 10.1126/scitranslmed.3010564 (2015).
21. Weathersby, P. K., Kolobow, T. & Stool, E. W. Relative thrombogenicity of polydimethylsiloxane and silicone rubber constituents. J Biomed Mater Res 9, 561-568, doi: 10.1002/jbm.820090604 (1975).
22. Duffy, D. C., McDonald, J. C., Schueller, O. J. & Whitesides, G. M. Rapid Prototyping of Microfluidic Systems in Poly(dimethylsiloxane). Anal Chem 70, 4974-4984, doi: 10.1021/ac980656z (1998).
23. Chisholm, C. L. et al. Ammonium tetrathiomolybdate treatment targets the copper transporter ATP7A and enhances sensitivity of breast cancer to cisplatin. Oncotarget, doi: 10.18632/oncotarget.12992 (2016).
24. Boukellal, H., Selimovic, S., Jia, Y. W., Cristobal, G. & Fraden, S. Simple, robust storage of drops and fluids in a microfluidic device. Lab on a Chip 9, 331-338, doi: 10.1039/b808579j (2009).
25. Zhang, Q. L. et al. The proteasome inhibitor bortezomib interacts synergistically with the histone deacetylase inhibitor suberoylanilide hydroxamic acid to induce T-leukemia/lymphoma cells apoptosis. Leukemia 23, 1507-1514, doi: 10.1038/leu.2009.41 (2009).
26. Nielsen, D., Dombernowsky, P., Larsen, S. K., Hansen, O. P. & Skovsgaard, T. Epirubicin or epirubicin and cisplatin as first-line therapy in advanced breast cancer. A phase III study. Cancer Chemother Pharmacol 46, 459-466, doi: 10.1007/s002800000178 (2000).
27. O'Brien, J., Wilson, I., Orton, T. & Pognan, F. Investigation of the Alamar Blue (resazurin) fluorescent dye for the assessment of mammalian cell cytotoxicity. Eur J Biochem 267, 5421-5426 (2000).
28. Hough, P. V. C inventer; United States Atomic Energy Commission, assignee. Method and means for recognizing complex patterns. United States patent US 3,069,654. 1962 Dec 18.
29. Gaugain, B., Barbet, J., Capelle, N., Roques, B. P. & Le Pecq, J. B. DNA Bifunctional intercalators. 2. Fluorescence properties and DNA binding interaction of an ethidium homodimer and an acridine ethidium heterodimer. Biochemistry 17, 5078-5088 (1978).
30. Decherchi, P., Cochard, P. & Gauthier, P. Dual staining assessment of Schwann cell viability within whole peripheral nerves using calcein-AM and ethidium homodimer. J Neurosci Methods 71, 205-213 (1997).
31. Otsuji, T. G. et al. A 3D sphere culture system containing functional polymers for large-scale human pluripotent stem cell production. Stem Cell Reports 2, 734-745, doi: 10.1016/j.stemcr.2014.03.012 (2014).
32. UK, C. R. England and Wales Survival (2010-2011) Summary. Cancer Research UK (2014).
33. Bithi, S. S. & Vanapalli, S. A. Microfluidic cell isolation technology for drug testing of single tumor cells and their clusters. Sci Rep 7, 41707, doi: 10.1038/srep41707 (2017).